7AE

N-[2-{4-[(2S)-4-(methylsulfonyl)morpholin-2-yl]-1,3-thiazol-2-yl}-4-(morpholin-4-yl)phenyl]-1H-imidazole-2-carboxamide

Created:	2016-09-21
Last modified:	2017-01-25

Find Related PDB Entry
1 entries where 7AE is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	61
Chiral Atom Count	1
Bond Count	65
Aromatic Bond Count	16

2D diagram of 7AE

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-[2-{4-[(2S)-4-(methylsulfonyl)morpholin-2-yl]-1,3-thiazol-2-yl}-4-(morpholin-4-yl)phenyl]-1H-imidazole-2-carboxamide
Systematic Name (OpenEye OEToolkits)	~{N}-[2-[4-[(2~{S})-4-methylsulfonylmorpholin-2-yl]-1,3-thiazol-2-yl]-4-morpholin-4-yl-phenyl]-1~{H}-imidazole-2-carboxamide
Formula	C₂₂ H₂₆ N₆ O₅ S₂
Molecular Weight	518.609
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	C1N(S(C)(=O)=O)CC(OC1)c2csc(n2)c3c(ccc(c3)N4CCOCC4)NC(c5nccn5)=O
SMILES	CACTVS	3.385	C[S](=O)(=O)N1CCO[CH](C1)c2csc(n2)c3cc(ccc3NC(=O)c4[nH]ccn4)N5CCOCC5
SMILES	OpenEye OEToolkits	2.0.6	CS(=O)(=O)N1CCOC(C1)c2csc(n2)c3cc(ccc3NC(=O)c4[nH]ccn4)N5CCOCC5
Canonical SMILES	CACTVS	3.385	C[S](=O)(=O)N1CCO[C@@H](C1)c2csc(n2)c3cc(ccc3NC(=O)c4[nH]ccn4)N5CCOCC5
Canonical SMILES	OpenEye OEToolkits	2.0.6	CS(=O)(=O)N1CCO[C@@H](C1)c2csc(n2)c3cc(ccc3NC(=O)c4[nH]ccn4)N5CCOCC5
InChI	InChI	1.03	InChI=1S/C22H26N6O5S2/c1-35(30,31)28-8-11-33-19(13-28)18-14-34-22(26-18)16-12-15(27-6-9-32-10-7-27)2-3-17(16)25-21(29)20-23-4-5-24-20/h2-5,12,14,19H,6-11,13H2,1H3,(H,23,24)(H,25,29)/t19-/m0/s1
InChIKey	InChI	1.03	WWTNLDQWEKRXNB-IBGZPJMESA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL4094158
PubChem	124037112
ChEMBL	CHEMBL4094158

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.